Back to Search
JEFFREY LIEBERMAN, M.D.
M.D.
Psychiatry Physician
NPI: 1457484131Individual
Specialties, Licenses & Credentials
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Biomarker Assessment of Glutamatergic Target Engagement
NCT02134951COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
NCT01920802COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
CATIE- Schizophrenia Trial
NCT00014001COMPLETEDPHASE4STUDY_DIRECTOR
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
NCT00816907COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
PMID 35314708·Schizophrenia (Heidelb)·2022
8-other
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia.
PMID 35488718·Mol Genet Genomic Med·2022
8-other
Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness.
PMID 34033271·J Clin Psychiatry·2021
4-observational
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
PMID 32220153·J Clin Psychiatry·2020
3-trial
Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
PMID 31009064·Biometrics·2019
8-other
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data.
PMID 30172739·Prog Neuropsychopharmacol Biol Psychiatry·2019
8-other
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
PMID 29167877·JAMA Psychiatry·2018
4-observational
Concomitant calcium channel blocker and antipsychotic therapy in patients with schizophrenia: Efficacy analysis of the CATIE-Sz phase 1 data.
PMID 29069114·Ann Clin Psychiatry·2018
8-other
Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
PMID 29444618·J Psychopharmacol·2018
2-rct
Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
PMID 28693755·Schizophr Res·2018
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1155 PARK AVE
NEW YORK, NY 10128 - Phone
- (646) 726-2767
Quick Facts
- NPI
- 1457484131
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile